FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Aasaan Loans IPO and Kronox Lab Sciences IPO.
Aasaan Loans IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Kronox Lab Sciences IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Aasaan Loans IPO | Kronox Lab Sciences IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Gretex Corporate Services Limited | Pantomath Capital Advisors Pvt Ltd |
Registrar | Bigshare Services Pvt Ltd | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aasaan Loans IPO is up to ₹132.00 Cr whereas the issue size of the Kronox Lab Sciences IPO is up to ₹130.15 Cr. The final issue price of Aasaan Loans IPO is ₹120.00 per share and of Kronox Lab Sciences IPO is ₹136.00 per share.
Aasaan Loans IPO | Kronox Lab Sciences IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹114.00 per share | ₹129.00 per share |
Issue Price (Upper) | ₹120.00 per share | ₹136.00 per share |
Issue Price (Final) | ₹120.00 per share | ₹136.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 125 shares | 110 shares |
Fresh Issue Size | 1,10,00,000 shares | |
Fresh Issue Size (Amount) | up to ₹132.00 Cr | |
OFS Issue Size | 95,70,000 shares | |
OFS Issue Size (Amount) | up to ₹130.15 Cr | |
Issue Size Total | 1,10,00,000 shares | 95,70,000 shares |
Issue Size Total (Amount) | up to ₹132.00 Cr | up to ₹130.15 Cr |
Aasaan Loans IPO opens on Jun 19, 2024, while Kronox Lab Sciences IPO opens on Jun 03, 2024. The closing date of Aasaan Loans IPO and Kronox Lab Sciences IPO is Jun 21, 2024, and Jun 05, 2024, respectively.
Aasaan Loans IPO | Kronox Lab Sciences IPO | |
---|---|---|
Anchor Bid Date | Jun 18, 2024 | May 31, 2024 |
Issue Open | Jun 19, 2024 | Jun 03, 2024 |
Issue Close | Jun 21, 2024 | Jun 05, 2024 |
Basis Of Allotment (Tentative) | Jun 24, 2024 | Jun 06, 2024 |
Initiation of Refunds (Tentative) | Jun 25, 2024 | Jun 07, 2024 |
Credit of Share (Tentative) | Jun 25, 2024 | Jun 07, 2024 |
Listing date (Tentative) | Jun 26, 2024 | Jun 10, 2024 |
Anchor Lockin End date 1 | Jul 24, 2024 | Jul 06, 2024 |
Anchor Lockin End date 2 | Sep 22, 2024 | Sep 04, 2024 |
Aasaan Loans IPO P/E ratio is , as compared to Kronox Lab Sciences IPO P/E ratio of 30.37.
Aasaan Loans IPO | Kronox Lab Sciences IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Akme Fintrade India Ltd Financial Information (Restated)Akme Fintrade India Ltd's revenue increased by 3.06% and profit after tax (PAT) rose by 283.5% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Kronox Lab Sciences Limited Financial Information (Restated)Kronox Lab Sciences Limited's revenue increased by 16.99% and profit after tax (PAT) rose by 21.94% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 56.01% | 99.98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 74.21% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 30.37 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹504.61 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 5.64%% | 25.66%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 33.15%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 2.49 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹3.87 | ₹4.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 5.81%% | 25.66%% |
In the Aasaan Loans IPO retail investors (RII) are offered 36,57,500 shares while in Kronox Lab Sciences IPO retail investors are offered 36,57,500 shares. Qualified institutional buyers (QIB) are offered 20,90,000 shares in Aasaan Loans IPO and 19,14,000 shares in Kronox Lab Sciences IPO.
Aasaan Loans IPO | Kronox Lab Sciences IPO | |
---|---|---|
Anchor Investor Reserveration | 31,35,000 shares | 28,71,000 shares |
Market Maker Reserveration | ||
QIB | 20,90,000 shares | 19,14,000 shares |
NII | 15,67,500 shares | 14,35,500 shares |
RII | 36,57,500 shares | 33,49,500 shares |
Employee | 5,50,000 shares | 0 shares |
Others | ||
Total | 78,65,000 shares | 66,99,000 shares |
Aasaan Loans IPO subscribed 54.49x in total, whereas Kronox Lab Sciences IPO subscribed 117.25x.
Aasaan Loans IPO | Kronox Lab Sciences IPO | |
---|---|---|
QIB (times) | 28.12x | 89.03x |
NII (times) | 129.98x | 301.92x |
Big NII (times) | 121.56x | 322.26x |
Small NII (times) | 146.83x | 261.22x |
RII (times) | 44.58x | 54.24x |
Employee (times) | 5.42x | |
Other (times) | ||
Total (times) | 54.49x | 117.25x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|